Abstract
In the previous study, hypertension prevalence, awareness, treatment and control for Han and others four ethnic minorities (Uygur, Hui, Mongolian and Dai) has not been clearly documented in China. Therefore we used the baseline data of Prospective Urban and Rural Epidemiology (PURE) for further detailed study. Adjusted rate were estimated and compared through logistic regression after adjustment of age, sex, location and education. Among the total of 7137 participants (Han: 1626, ethnic minorities: 5511), hypertension prevalence, awareness, treatment and control were 2922(40.9%), 1199(41.0%), 873(29.9%) and 147(5.0%), respectively. The most commonly used antihypertensive drugs are traditional compound drugs (6.2%) and calcium channel blockers (5.2%). Hypertension prevalence in ethnic minorities was significantly higher than in Han (42.4% vs 34.4%, P<0.0001), while control rate (1.6% vs 9.8%, P=0.0198) and treated control rate (8.0% vs 25.0%, P=0.0200) were lower. Compared with Han counterparts, Dai had a higher prevalence (50.8% vs 29.9%, P<0.0001). Uygur had a lower treatment rate (33.2% vs 20.6%, P=0.0110). Mongolian had a lower control (5.1% vs 16.1%, P=0.0046) and treated control rate (14.1% vs 50.3%, P=0.0013). In conclusions, our study showed ethnic minorities had higher hypertension prevalence, especially for Dai and lower control and treated control rate for Mongolian. Hence, we need more attention with respect to hypertension in ethnic minorities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
World Health Organization Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. World Health Organization: Geneva, 2009.
Wang Q . High blood pressure a growing threat to China's public health[Internet]. China Daily (Beijing), c1995–2015. Available from: http://www.chinadaily.com.cn/cndy/2013-04/08/content_16381678.html (cited 7 September 2014).
National Center for Cardiovascular Diseases Report on Cardiovascular Disease in China (2007) [in Chinese]. Encyclopedia of China Publishing House: Beijing, 2007.
Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P et al. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40 (6): 920–927.
Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118 (25): 2679–2686.
Chow CK . Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310 (9): 959.
Chen Z, Meltzer D . Beefing up with the Chans: evidence for the effects of relative income and income inequality on health from the China Health and Nutrition Survey. Soc Sci Med 2008; 66 (11): 2206–2217.
Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S and Group PI-W. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 158 (1): 1–7 e1.
Gao Y, Chen G, Tian H, Lin L, Lu J, Weng J et al. Prevalence of hypertension in china: a cross-sectional study. PLoS ONE 2013; 8 (6): e65938.
Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002; 40 (6): 920–927.
Tao S, Wu X, Duan X, Fang W, Hao J, Fan D et al. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J 1995; 108 (7): 483–489.
Wang Z, Wang X, Chen Z, Wang W, Zhu H, Chen W et al. Hypertension control in community health centers across china: analysis of antihypertensive drug treatment patterns. Am J Hypertens 2014; 27: 252–259.
Yisong H, Chonghua Y, Wenzhi W, Jianpin H . Survey on the prevalence of hypertension in different ethnic groups in China in 2002. J Hypertens Res 2006; 35 (5): 573–575.
Ferdinand KC . Hypertension in minority populations. J Clin Hypertens 2006; 8 (5): 365–368.
Centers for Disease Control. Prevention. Prevention. Racial/ethnic disparities in prevalence, treatment, and control of hypertension—United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2005; 54 (1): 7.
Yao X-G, Frommlet F, Zhou L, Zu F, Wang H-M, Yan Z-T et al. The prevalence of hypertension, obesity and dyslipidemia in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang. BMC Public Health 2010; 10 (1): 91.
Lu Z, Lu Z, Zhu Y, Yan Z, Liu X, Yan S et al. Enhanced hypertension prevalence in non-Han Chinese minorities from Xinjiang Province, China. Hypertens Res 2009; 32 (12): 1097–1103.
Yang S, Liu S, Wang Y, Wan H, Zhao D, Li Y et al. High blood pressure in Chinese ethnic minorities: report from rural Yunnan province. Am J Hypertens 2011; 24 (11): 1209–1214.
He J, Klag MJ, Whelton PK, Chen JY, Mo JP, Qian MC et al. Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol 1991; 134 (10): 1085–1101.
Black ML, Wang W, Bittles AH . A genome-based study of the Muslim Hui community and the Han population of Liaoning Province, PR China. Hum Biol 2001; 73 (6): 801–813.
Gu Q, Burt VL, Dillon CF, Yoon S . Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation 2012; 126 (17): 2105–2114.
Ling RE, Liu F, Lu XQ, Wang W . Emerging issues in public health: a perspective on China's healthcare system. Public Health 2011; 125 (1): 9–14.
Shao S, Zhao F, Wang J, Feng L, Lu X, Du J et al. The ecology of medical care in Beijing. PLoS ONE 2013; 8 (12): e82446.
Liao Y, Tucker P, Okoro CA, Giles WH, Mokdad AH, Harris VB . REACH 2010 surveillance for health status in minority communities—-United States, 2001—2002. MMWR Surveill Summ 2004; 53 (6): 1–36.
Zhang M, Meng Y, Yang Y, Liu Y, Dong C, Xiao J et al. Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China. BMC Public Health 2011; 11 (1): 301.
Acknowledgements
We wish to acknowledge the contribution of the participants to PURE-China study as well as local medical personnel for data collection.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Gu, H., Li, W., Yang, J. et al. Hypertension prevalence, awareness, treatment and control among Han and four ethnic minorities (Uygur, Hui, Mongolian and Dai) in China. J Hum Hypertens 29, 555–560 (2015). https://doi.org/10.1038/jhh.2014.123
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2014.123
This article is cited by
-
Association between ethnicity and health knowledge among the floating population in China
Cost Effectiveness and Resource Allocation (2022)
-
Effectiveness of a clinical decision support system for hypertension management in primary care: study protocol for a pragmatic cluster-randomized controlled trial
Trials (2022)
-
Factors associated with awareness, treatment and control of hypertension among 3579 hypertensive adults in China: data from the China Health and Nutrition Survey
BMC Public Health (2021)
-
Prevalence, awareness, treatment, and control of hypertension in Northern China: a cross-sectional study
BMC Cardiovascular Disorders (2021)
-
Relationship between the duration of smoking and blood pressure in Han and ethnic minority populations: a cross-sectional study in China
BMC Public Health (2021)